| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 18.512 | 24.257 | 23.710 | 31.628 | 60.282 | 82.344 | 40.420 | 83.454 | 115.530 | 136.299 |
| Total Income - EUR | 18.512 | 24.257 | 45.601 | 42.419 | 64.547 | 87.423 | 40.934 | 84.463 | 116.044 | 141.234 |
| Total Expenses - EUR | 26.747 | 28.175 | 32.877 | 41.421 | 64.888 | 86.344 | 57.816 | 87.247 | 110.982 | 131.735 |
| Gross Profit/Loss - EUR | -8.235 | -3.918 | 12.724 | 998 | -341 | 1.079 | -16.882 | -2.784 | 5.062 | 9.499 |
| Net Profit/Loss - EUR | -8.820 | -4.170 | 12.262 | 577 | -950 | 614 | -17.086 | -3.630 | 3.899 | 5.256 |
| Employees | 2 | 2 | 3 | 3 | 4 | 5 | 4 | 3 | 3 | 3 |
Check the financial reports for the company - Elviroxan Com S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 670 | 527 | 385 | 5.711 | 4.982 | 5.169 | 5.806 | 5.697 | 4.489 | 6.181 |
| Current Assets | 12.134 | 8.473 | 9.474 | 15.654 | 14.589 | 18.659 | 30.494 | 29.050 | 25.304 | 27.710 |
| Inventories | 11.846 | 8.026 | 8.858 | 12.975 | 12.657 | 17.848 | 26.372 | 22.560 | 14.058 | 19.248 |
| Receivables | 244 | 369 | 363 | 795 | 1.328 | 655 | 4.094 | 4.390 | 3.703 | 2.218 |
| Cash | 45 | 77 | 253 | 1.884 | 605 | 156 | 28 | 2.101 | 7.543 | 6.244 |
| Shareholders Funds | -58.340 | -61.915 | -48.605 | -47.136 | -47.173 | -45.664 | -61.738 | -65.559 | -61.462 | -55.862 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 71.144 | 70.915 | 58.464 | 63.083 | 62.305 | 65.662 | 94.807 | 97.581 | 89.052 | 87.751 |
| Income in Advance | 0 | 0 | 0 | 5.417 | 4.776 | 4.160 | 3.554 | 3.050 | 2.527 | 2.001 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Elviroxan Com S.r.l.